Advertisement

Current Tropical Medicine Reports

, Volume 6, Issue 4, pp 239–249 | Cite as

Current Perspectives on Maternal Influenza Immunization

  • Annette K. ReganEmail author
  • Siri E. Håberg
  • Deshayne B. Fell
Vaccines in Pregnant Women & Infants (D Schwartz and C Krubiner, Section Editors)
  • 20 Downloads
Part of the following topical collections:
  1. Topical Collection on Vaccines in Pregnant Women & Infants

Abstract

Purpose of Review

Pregnant women and young infants are more likely to experience severe complications associated with influenza infection and are at increased risk of hospitalization. Influenza vaccination during pregnancy produces antibodies which protect the mother against infection, and due to transplacental transfer of maternal antibodies before birth, it also protects the infant in the first few months of life.

Recent Findings

In many countries, influenza vaccination is recommended during pregnancy to protect mothers and their infants. In fact, influenza vaccine is the most widely used vaccine in pregnancy globally. When administered during pregnancy, the vaccine has been shown to be safe and effective for both mothers and their infants. Despite the health benefits, acceptance of influenza vaccine is low during pregnancy, indicating many women and infants are not protected against influenza.

Summary

Concerted efforts are needed globally to improve the proportion of women and young infants who receive the health benefits of influenza vaccination.

Keywords

Influenza vaccines Influenza Maternal vaccination Pregnant women Infant health 

Notes

Funding Information

This work was partly funded by the Norwegian Research council’s Centre’s of Excellence funding scheme (#262700).

Compliance With Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–300.  https://doi.org/10.1016/s0140-6736(17)33293-2.CrossRefPubMedGoogle Scholar
  2. 2.
    CDC. Flu symptoms and complications. 2019. https://www.cdc.gov/flu/symptoms/symptoms.htm. Accessed August 14 2019.
  3. 3.
    Yudin MH. Risk management of seasonal influenza during pregnancy: current perspectives. Int J Womens Health. 2014;6:681–9.  https://doi.org/10.2147/IJWH.S47235.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerg Infect Dis. 2008;14(1):95–100.  https://doi.org/10.3201/eid1401.070667.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg Infect Dis. 2006;12(11):1638–43.  https://doi.org/10.3201/eid1211.060152.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Raj RS, Bonney EA, Phillippe M. Influenza, immune system, and pregnancy. Reprod Sci. 2014;21(12):1434–51.  https://doi.org/10.1177/1933719114537720.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Littauer EQ, Esser ES, Antao OQ, Vassilieva EV, Compans RW, Skountzou I. H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation. PLoS Pathog. 2017;13(11):e1006757.  https://doi.org/10.1371/journal.ppat.1006757.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Ohfuji S, Deguchi M, Tachibana D, Koyama M, Takagi T, Yoshioka T, et al. Estimating influenza disease burden among pregnant women: application of self-control method. Vaccine. 2017;35(36):4811–6.  https://doi.org/10.1016/j.vaccine.2017.07.006.CrossRefPubMedGoogle Scholar
  9. 9.
    Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ. 2007;176(4):463–8.  https://doi.org/10.1503/cmaj.061435.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Vilca LM, Verma A, Bonati M, Campins M. Impact of influenza on outpatient visits and hospitalizations among pregnant women in Catalonia, Spain. J Infect. 2018;77(6):553–60.  https://doi.org/10.1016/j.jinf.2018.06.015.CrossRefPubMedGoogle Scholar
  11. 11.
    Katz MA, Gessner BD, Johnson J, Skidmore B, Knight M, Bhat N, et al. Incidence of influenza virus infection among pregnant women: a systematic review. BMC Pregnancy Childbirth. 2017;17(1):155–12.  https://doi.org/10.1186/s12884-017-1333-5.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303(15):1517–25.  https://doi.org/10.1001/jama.2010.479.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Oboho IK, Reed C, Gargiullo P, Leon M, Aragon D, Meek J, et al. Benefit of early initiation of influenza antiviral treatment to pregnant women hospitalized with laboratory-confirmed influenza. J Infect Dis. 2016;214(4):507–15.  https://doi.org/10.1093/infdis/jiw033.CrossRefPubMedGoogle Scholar
  14. 14.
    Fell DB, Savitz DA, Kramer MS, Gessner BD, Katz MA, Knight M, et al. Maternal influenza and birth outcomes: systematic review of comparative studies. BJOG. 2017;124(1):48–59.  https://doi.org/10.1111/1471-0528.14143.CrossRefPubMedGoogle Scholar
  15. 15.
    Håberg SE, Trogstad L, Gunnes N, Wilcox AJ, Gjessing HK, Samuelsen SO, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. New Engl J Med. 2013;368(4):333–40.  https://doi.org/10.1056/NEJMoa1207210.CrossRefPubMedGoogle Scholar
  16. 16.
    Fell DB, Platt RW, Basso O, Wilson K, Kaufman JS, Buckeridge DL, et al. The relationship between 2009 pandemic H1N1 influenza during pregnancy and preterm birth: a population-based cohort study. Epidemiology. 2018;29(1):107–16.  https://doi.org/10.1097/ede.0000000000000753.CrossRefPubMedGoogle Scholar
  17. 17.
    Hansen C, Desai S, Bredfeldt C, Cheetham C, Gallagher M, Li DK, et al. A large, population-based study of 2009 pandemic influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates. J Infect Dis. 2012;206(8):1260–8.  https://doi.org/10.1093/infdis/jis488.CrossRefPubMedGoogle Scholar
  18. 18.
    •• Katz J, Englund JA, Steinhoff MC, Khatry SK, Shrestha L, Kuypers J, et al. Impact of timing of influenza vaccination in pregnancy on transplacental antibody transfer, influenza incidence, and birth outcomes: a randomized trial in rural Nepal. Clin Infect Dis. 2018;67(3):334–40.  https://doi.org/10.1093/cid/ciy090Authors report evidence from clinical trial evaluating cord blood antibody titers by gestational age at influenza vaccine administration. Findings show that vaccine efficacy did not vary by gestational age at vaccination, which has implications for immunization policy and practice.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. New Engl J Med. 2000;342(4):225–31.  https://doi.org/10.1056/nejm200001273420401.CrossRefPubMedGoogle Scholar
  20. 20.
    Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK, et al. The underrecognized burden of influenza in young children. New Engl J Med. 2006;355(1):31–40.  https://doi.org/10.1056/NEJMoa054869.CrossRefPubMedGoogle Scholar
  21. 21.
    Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, Glover MJ, et al. Influenza-associated deaths among children in the United States, 2003-2004. New Engl J Med. 2005;353(24):2559–67.  https://doi.org/10.1056/NEJMoa051721.CrossRefPubMedGoogle Scholar
  22. 22.
    Blyth CC, Macartney KK, Hewagama S, Senenayake S, Friedman ND, Simpson G, et al. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN). Euro Surveill. 2016;21(30).  https://doi.org/10.2807/1560-7917.es.2016.21.30.30301.
  23. 23.
    MacDonald NE, McDonald JC. Canadian Paediatric Society ID, Immunization C. The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age. Paediatr Child Health. 2014;19(9):e121–e2.CrossRefGoogle Scholar
  24. 24.
    Saji F, Samejima Y, Kamiura S, Koyama M. Dynamics of immunoglobulins at the feto-maternal interface. Rev Reprod. 1999;4(2):81–9.CrossRefGoogle Scholar
  25. 25.
    Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol. 1996;36(5):248–55.CrossRefGoogle Scholar
  26. 26.
    Esposito S, Bosis S, Morlacchi L, Baggi E, Sabatini C, Principi N. Can infants be protected by means of maternal vaccination? Clin Microbiol Infect. 2012;18(Suppl 5):85–92.  https://doi.org/10.1111/j.1469-0691.2012.03936.x.CrossRefPubMedGoogle Scholar
  27. 27.
    Calvert A, Jones CE. Placental transfer of antibody and its relationship to vaccination in pregnancy. Curr Opinion Infect Dis. 2017;30(3):268–73.  https://doi.org/10.1097/qco.0000000000000372.CrossRefGoogle Scholar
  28. 28.
    • Omer SB. Maternal immunization. New Engl J Med. 2017;376(13):1256–67.  https://doi.org/10.1056/NEJMra1509044Review article which provides a summary of the results of three recent clinical trials evaluating prenatal influenza vaccine efficacy against maternal and infant infection.CrossRefPubMedGoogle Scholar
  29. 29.
    Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, et al. Effectiveness of maternal influenza immunization in mothers and infants. New Engl J Med. 2008;359(15):1555–64.  https://doi.org/10.1056/NEJMoa0708630.CrossRefPubMedGoogle Scholar
  30. 30.
    Tapia MD, Sow SO, Tamboura B, Teguete I, Pasetti MF, Kodio M, et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial. Lancet Infect Dis. 2016;16(9):1026–35.  https://doi.org/10.1016/s1473-3099(16)30054-8.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    • Steinhoff MC, Katz J, Englund JA, Khatry SK, Shrestha L, Kuypers J, et al. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial. Lancet Infect Dis. 2017;17(9):981–9.  https://doi.org/10.1016/s1473-3099(17)30252-9Results from this clinical trial suggest that influenza vaccination of pregnant women throughout the year would offer significant protection to pregnant women and their infants in subtropical regions, where influenza circulates year-round.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, et al. Influenza vaccination of pregnant women and protection of their infants. New Engl J Med. 2014;371(10):918–31.  https://doi.org/10.1056/NEJMoa1401480.CrossRefPubMedGoogle Scholar
  33. 33.
    Marshall H, McMillan M, Andrews RM, Macartney K, Edwards K. Vaccines in pregnancy: the dual benefit for pregnant women and infants. Hum Vaccin Immunother. 2016;12(4):848–56.  https://doi.org/10.1080/21645515.2015.1127485.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Jamieson DJ, Kissin DM, Bridges CB, Rasmussen SA. Benefits of influenza vaccination during pregnancy for pregnant women. Am J Obstet Gynecol. 2012;207(3 Suppl):S17–20.  https://doi.org/10.1016/j.ajog.2012.06.070.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Burney LE. Influenza immunization: statement. Public Health Rep. 1960;75(10):944.CrossRefGoogle Scholar
  36. 36.
    Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis. 2006;12(1):9–14.  https://doi.org/10.3201/eid1201.051254.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Englund JA. Maternal immunization with inactivated influenza vaccine: rationale and experience. Vaccine. 2003;21(24):3460–4.  https://doi.org/10.1016/s0264-410x(03)00351-7.CrossRefPubMedGoogle Scholar
  38. 38.
    Klebanoff MA. The Collaborative Perinatal Project: a 50-year retrospective. Paediatr Perinat Epidemiol. 2009;23(1):2–8.  https://doi.org/10.1111/j.1365-3016.2008.00984.x.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Heinonen OP, Shapiro S, Monson RR, Hartz SC, Rosenberg L, Slone D. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol. 1973;2(3):229–35.  https://doi.org/10.1093/ije/2.3.229.CrossRefPubMedGoogle Scholar
  40. 40.
    CDC. Recommendations for influenza immunization and control in the civilian population - 1965-66. MMWR Morb Mortal Wkly Rep. 1965;14(24):203–8.Google Scholar
  41. 41.
    CDC. Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1995;44(Rr-3):1–22.Google Scholar
  42. 42.
    CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2004;53(Rr-6):1–40.Google Scholar
  43. 43.
    CDC. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 influenza season. MMWR Morb Mortal Wkly Rep. 2019;68(3):1–21.  https://doi.org/10.15585/mmwr.rr6803a1.CrossRefGoogle Scholar
  44. 44.
  45. 45.
    ACOG. Influenza vaccination during pregnancy. ACOG Committee Opinion No. 732. Obstet Gynecol. 2018;131:e109–14.CrossRefGoogle Scholar
  46. 46.
    PHAC. An Advisory Committee Statement (ACS) NAtional Advisory Committee on Immunization (NACI): canadian immunization guide chapter on influenza and statement of seaosnal influenza vaccine for 2019-20. 2019. https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/canadian-immunization-guide-statement-seasonal-influenza-vaccine-2019-2020.html. Accessed 6 September 2019.
  47. 47.
    ECDC. Seasonal influenza vaccination in Europe: vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons: 2007-2008 to 2014-15. Stockholm: ECDC; 2017.Google Scholar
  48. 48.
    CDC. Influenza vaccination in pregnancy: practices among obstetrician-gynecologists--United States, 2003-04 influenza season. MMWR Morb Mortal Wkly Rep. 2005;54(41):1050–2.Google Scholar
  49. 49.
    Lu P, Bridges CB, Euler GL, Singleton JA. Influenza vaccination of recommended adult populations, U.S., 1989-2005. Vaccine. 2008;26(14):1786–93.  https://doi.org/10.1016/j.vaccine.2008.01.040.CrossRefPubMedGoogle Scholar
  50. 50.
    Schrag SJ, Fiore AE, Gonik B, Malik T, Reef S, Singleton JA, et al. Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol. 2003;101(4):704–10.PubMedGoogle Scholar
  51. 51.
    WHO. Swine flu illness in the United States and Mexico - update 2. https://www.who.int/csr/don/2009_04_26/en/. Accessed August 12 2019.
  52. 52.
    WHO. Influenza A(H1N1) - update 41. https://www.who.int/csr/don/2009_05_29/en/. Accessed August 12 2019.
  53. 53.
    WHO. Pandemic (H1N1) 2009 - update 61. https://www.who.int/csr/don/2009_08_12/en/. Accessed August 12 2019.
  54. 54.
    ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ. 2010;340:c1279.  https://doi.org/10.1136/bmj.c1279.CrossRefGoogle Scholar
  55. 55.
    CDC. Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May 2009. MMWR Morb Mortal Wkly Rep. 2009;58(18):497–500.Google Scholar
  56. 56.
    CDC. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep. 2009;58(19):521–4.Google Scholar
  57. 57.
    CDC. Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women--10 states, 2009-10 influenza season. MMWR Morb Mortal Wkly Rep. 2010;59(47):1541–5.Google Scholar
  58. 58.
    CDC. Influenza vaccination coverage during pregnancy - selected sites, United States, 2005-06 through 2013-14 influenza vaccine seasons. MMWR Morb Mortal Wkly Rep. 2016;65(48):1370–3.  https://doi.org/10.15585/mmwr.mm6548a3.CrossRefGoogle Scholar
  59. 59.
    McCarthy EA, Pollock WE, Tapper L, Sommerville M, McDonald S. Increasing uptake of influenza vaccine by pregnant women post H1N1 pandemic: a longitudinal study in Melbourne, Australia, 2010 to 2014. BMC Pregnancy Childbirth. 2015;15:53–7.  https://doi.org/10.1186/s12884-015-0486-3.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Regan AK, Mak DB, Hauck YL, Gibbs R, Tracey L, Effler PV. Trends in seasonal influenza vaccine uptake during pregnancy in Western Australia: implications for midwives. Women Birth. 2016;29(5):423–9.  https://doi.org/10.1016/j.wombi.2016.01.009.CrossRefPubMedGoogle Scholar
  61. 61.
    Wiley KE, Massey PD, Cooper SC, Wood NJ, Ho J, Quinn HE, et al. Uptake of influenza vaccine by pregnant women: a cross-sectional survey. Med J Aust. 2013;198(7):373–5.CrossRefGoogle Scholar
  62. 62.
    Seo J, Lim J. Trends in influenza vaccination coverage rates in South Korea from 2005 to 2014: effect of public health policies on vaccination behavior. Vaccine. 2018;36(25):3666–73.  https://doi.org/10.1016/j.vaccine.2018.05.024.CrossRefPubMedGoogle Scholar
  63. 63.
    WHO. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rev. 2012;87(47):461–76.Google Scholar
  64. 64.
    Ortiz JR, Perut M, Dumolard L, Wijesinghe PR, Jorgensen P, Ropero AM, et al. A global review of national influenza immunization policies: analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization. Vaccine. 2016;34(45):5400–5.  https://doi.org/10.1016/j.vaccine.2016.07.045.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Munoz FM, Jackson LA, Swamy GK, Edwards KM, Frey SE, Stephens I, et al. Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women. Vaccine. 2018;36(52):8054–61.  https://doi.org/10.1016/j.vaccine.2018.10.088.CrossRefPubMedGoogle Scholar
  66. 66.
    Simoes EAF, Nunes MC, Carosone-Link P, Madimabe R, Ortiz JR, Neuzil KM, et al. Trivalent influenza vaccination randomized control trial of pregnant women and adverse fetal outcomes. Vaccine. 2019;37(36):5397–403.  https://doi.org/10.1016/j.vaccine.2019.07.024.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis. 1979;140(2):141–6.  https://doi.org/10.1093/infdis/140.2.141.CrossRefPubMedGoogle Scholar
  68. 68.
    Steinhoff MC, Omer SB, Roy E, El Arifeen S, Raqib R, Dodd C, et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ. 2012;184(6):645–53.  https://doi.org/10.1503/cmaj.110754.CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    McHugh L, Andrews RM, Lambert SB, Viney KA, Wood N, Perrett KP, et al. Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: the FluMum study. Vaccine. 2017;35(10):1403–9.  https://doi.org/10.1016/j.vaccine.2017.01.075.CrossRefPubMedGoogle Scholar
  70. 70.
    McHugh L, Marshall HS, Perrett KP, Nolan T, Wood N, Lambert SB, et al. The safety of influenza and pertussis vaccination in pregnancy in a cohort of Australian mother-infant pairs, 2012-2015: the FluMum Study. Clin Infect Dis. 2019;68(3):402–8.  https://doi.org/10.1093/cid/ciy517.CrossRefPubMedGoogle Scholar
  71. 71.
    Regan AK, Moore HC, de Klerk N, Omer SB, Shellam G, Mak DB, et al. Seasonal trivalent influenza vaccination during pregnancy and the incidence of stillbirth: population-based retrospective cohort study. Clin Infect Dis. 2016;62(10):1221–7.  https://doi.org/10.1093/cid/ciw082.CrossRefPubMedGoogle Scholar
  72. 72.
    Nordin JD, Kharbanda EO, Benitez GV, Nichol K, Lipkind H, Naleway A, et al. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol. 2013;121(3):519–25.  https://doi.org/10.1097/AOG.0b013e3182831b83.CrossRefPubMedGoogle Scholar
  73. 73.
    Nordin JD, Kharbanda EO, Vazquez-Benitez G, Lipkind H, Lee GM, Naleway AL. Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events. Vaccine. 2014;32(39):4985–92.  https://doi.org/10.1016/j.vaccine.2014.07.017.CrossRefPubMedGoogle Scholar
  74. 74.
    Olsen SJ, Mirza SA, Vonglokham P, Khanthamaly V, Chitry B, Pholsena V, et al. The effect of influenza vaccination on birth outcomes in a cohort of pregnant women in Lao PDR, 2014-2015. Clin Infect Dis. 2016;63(4):487–94.  https://doi.org/10.1093/cid/ciw290.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Baum U, Leino T, Gissler M, Kilpi T, Jokinen J. Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: a cohort study of pregnancies stratified by trimester of vaccination. Vaccine. 2015;33(38):4850–7.  https://doi.org/10.1016/j.vaccine.2015.07.061.CrossRefPubMedGoogle Scholar
  76. 76.
    Chavant F, Ingrand I, Jonville-Bera AP, Plazanet C, Gras-Champel V, Lagarce L, et al. The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza. Drug Saf. 2013;36(6):455–65.  https://doi.org/10.1007/s40264-013-0030-1.CrossRefPubMedGoogle Scholar
  77. 77.
    Cleary BJ, Rice U, Eogan M, Metwally N, McAuliffe F. 2009 A/H1N1 influenza vaccination in pregnancy: uptake and pregnancy outcomes - a historical cohort study. Eur J Obstet Gynecol Reprod Biol. 2014;178:163–8.  https://doi.org/10.1016/j.ejogrb.2014.04.015.CrossRefPubMedGoogle Scholar
  78. 78.
    Heikkinen T, Young J, van Beek E, Franke H, Verstraeten T, Weil JG, et al. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol. 2012;207(3):177.e1–8.  https://doi.org/10.1016/j.ajog.2012.07.007.CrossRefGoogle Scholar
  79. 79.
    Louik C, Kerr S, Van Bennekom CM, Chambers C, Jones KL, Schatz M, et al. Safety of the 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: preterm delivery and specific malformations, a study from the case-control arm of VAMPSS. Vaccine. 2016;34(37):4450–9.  https://doi.org/10.1016/j.vaccine.2016.06.078.CrossRefPubMedGoogle Scholar
  80. 80.
    Naleway AL, Irving SA, Henninger ML, Li DK, Shifflett P, Ball S, et al. Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies. Vaccine. 2014;32(26):3122–7.  https://doi.org/10.1016/j.vaccine.2014.04.021.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Oppermann M, Fritzsche J, Weber-Schoendorfer C, Keller-Stanislawski B, Allignol A, Meister R, et al. A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012;30(30):4445–52.  https://doi.org/10.1016/j.vaccine.2012.04.081.CrossRefPubMedGoogle Scholar
  82. 82.
    Tavares F, Nazareth I, Monegal JS, Kolte I, Verstraeten T, Bauchau V. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine. 2011;29(37):6358–65.  https://doi.org/10.1016/j.vaccine.2011.04.114.CrossRefPubMedGoogle Scholar
  83. 83.
    Omon E, Damase-Michel C, Hurault-Delarue C, Lacroix I, Montastruc JL, Oustric S, et al. Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study. Vaccine. 2011;29(52):9649–54.  https://doi.org/10.1016/j.vaccine.2011.10.034.CrossRefPubMedGoogle Scholar
  84. 84.
    Chambers CD, Johnson D, Xu R, Luo Y, Louik C, Mitchell AA, et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine. 2013;31(44):5026–32.  https://doi.org/10.1016/j.vaccine.2013.08.097.CrossRefPubMedGoogle Scholar
  85. 85.
    Chambers CD, Johnson DL, Xu R, Luo YJ, Louik C, Mitchell AA, et al. Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS. Vaccine. 2016;34(37):4443–9.  https://doi.org/10.1016/j.vaccine.2016.06.054.CrossRefPubMedGoogle Scholar
  86. 86.
    Zerbo O, Modaressi S, Chan B, Goddard K, Lewis N, Bok K, et al. No association between influenza vaccination during pregnancy and adverse birth outcomes. Vaccine. 2017;35(24):3186–90.  https://doi.org/10.1016/j.vaccine.2017.04.074.CrossRefPubMedGoogle Scholar
  87. 87.
    Regan AK, Blyth CC, Effler PV. Using SMS technology to verify the safety of seasonal trivalent influenza vaccine for pregnant women in real time. Med J Aust. 2013;199(11):744–6.CrossRefGoogle Scholar
  88. 88.
    Regan AK, Tracey L, Blyth CC, Mak DB, Richmond PC, Shellam G, et al. A prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnant women. BMC Pregnancy Childbirth. 2015;15:61–7.  https://doi.org/10.1186/s12884-015-0495-2.CrossRefPubMedPubMedCentralGoogle Scholar
  89. 89.
    • Regan AK, Tracey LE, Blyth CC, Richmond PC, Effler PV. A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancy. Vaccine. 2016;34(20):2299–304.  https://doi.org/10.1016/j.vaccine.2016.03.084Results from this prospective cohort study identified no increase in adverse events following influenza vaccine, given on its own or in combination with pertussis vaccine.CrossRefPubMedGoogle Scholar
  90. 90.
    Carcione D, Blyth CC, Richmond PC, Mak DB, Effler PV. Safety surveillance of influenza vaccine in pregnant women. Austr N Z J Obstet Gynecol. 2013;53(1):98–9.  https://doi.org/10.1111/ajo.12034.CrossRefGoogle Scholar
  91. 91.
    Stockwell MS, Cano M, Jakob K, Broder KR, Gyamfi-Bannerman C, Castano PM, et al. Feasibility of text message influenza vaccine safety monitoring during pregnancy. Am J Prev Med. 2017;53(3):282–9.  https://doi.org/10.1016/j.amepre.2017.03.014.CrossRefPubMedPubMedCentralGoogle Scholar
  92. 92.
    Moro P, Baumblatt J, Lewis P, Cragan J, Tepper N, Cano M. Surveillance of adverse events after seasonal influenza vaccination in pregnant women and their infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016. Drug Saf. 2017;40(2):145–52.  https://doi.org/10.1007/s40264-016-0482-1.CrossRefPubMedPubMedCentralGoogle Scholar
  93. 93.
    Haber P, Moro PL, Cano M, Lewis P, Stewart B, Shimabukuro TT. Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014. Vaccine. 2015;33(16):1987–92.  https://doi.org/10.1016/j.vaccine.2015.01.080.CrossRefPubMedGoogle Scholar
  94. 94.
    Bratton KN, Wardle MT, Orenstein WA, Omer SB. Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis. Clin Infect Dis. 2015;60(5):e11–9.  https://doi.org/10.1093/cid/ciu915.CrossRefPubMedGoogle Scholar
  95. 95.
    Fell DB, Platt RW, Lanes A, Wilson K, Kaufman JS, Basso O, et al. Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG. 2015;122(1):17–26.  https://doi.org/10.1111/1471-0528.12977.CrossRefPubMedGoogle Scholar
  96. 96.
    McMillan M, Porritt K, Kralik D, Costi L, Marshall H. Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine. 2015;33(18):2108–17.  https://doi.org/10.1016/j.vaccine.2015.02.068.CrossRefPubMedGoogle Scholar
  97. 97.
    Polyzos KA, Konstantelias AA, Pitsa CE, Falagas ME. Maternal influenza vaccination and risk for congenital malformations: a systematic review and meta-analysis. Obstet Gynecol. 2015;126(5):1075–84.  https://doi.org/10.1097/aog.0000000000001068.CrossRefPubMedGoogle Scholar
  98. 98.
    Nunes MC, Aqil AR, Omer SB, Madhi SA. The effects of influenza vaccination during pregnancy on birth outcomes: a systematic review and meta-Analysis. Am J Perinatol. 2016;33(11):1104–14.  https://doi.org/10.1055/s-0036-1586101.CrossRefPubMedGoogle Scholar
  99. 99.
    Giles ML, Krishnaswamy S, Macartney K, Cheng A. The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review. Hum Vaccin Immunother. 2019;15(3):687–99.  https://doi.org/10.1080/21645515.2018.1540807.CrossRefPubMedGoogle Scholar
  100. 100.
    Hviid A, Svanstrom H, Molgaard-Nielsen D, Lambach P. Association between pandemic influenza A(H1N1) vaccination in pregnancy and early childhood morbidity in offspring. JAMA Pediatr. 2017;171(3):239–48.  https://doi.org/10.1001/jamapediatrics.2016.4023.CrossRefPubMedGoogle Scholar
  101. 101.
    Zerbo O, Qian Y, Yoshida C, Fireman BH, Klein NP, Croen LA. Association between influenza infection and vaccination during pregnancy and risk of Autism Spectrum Disorder. JAMA Pediatr. 2017;171(1):e163609.  https://doi.org/10.1001/jamapediatrics.2016.3609.CrossRefPubMedGoogle Scholar
  102. 102.
    • Walsh LK, Donelle J, Dodds L, Hawken S, Wilson K, Benchimol EI, et al. Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study. BMJ. 2019;366:l4151.  https://doi.org/10.1136/bmj.l4151First cohort study to evaluate the risk of a range of pre-specified pediatric health outcomes associated with 2009 monovalent pandemic A/H1N1 vaccination during pregnancy.CrossRefPubMedPubMedCentralGoogle Scholar
  103. 103.
    •• Cuningham W, Geard N, Fielding JE, Braat S, Madhi SA, Nunes MC, et al. Optimal timing of influenza vaccine during pregnancy: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2019;13(5):438–52.  https://doi.org/10.1111/irv.12649Recent systematic review which highlights differences in the immunogenicity of influenza vaccine administered at different stages of pregnancy as observed in matenral sera and cord blood.CrossRefPubMedPubMedCentralGoogle Scholar
  104. 104.
    Kharbanda EO, Vazquez-Benitez G, Romitti PA, Naleway AL, Cheetham TC, Lipkind HS, et al. First trimester influenza vaccination and risks for major structural birth defects in offspring. J Pediatr. 2017;187:234–9.e4.  https://doi.org/10.1016/j.jpeds.2017.04.039.CrossRefPubMedPubMedCentralGoogle Scholar
  105. 105.
    Sheffield JS, Greer LG, Rogers VL, Roberts SW, Lytle H, McIntire DD, et al. Effect of influenza vaccination in the first trimester of pregnancy. Obstet Gynecol. 2012;120(3):532–7.  https://doi.org/10.1097/AOG.0b013e318263a278.CrossRefPubMedGoogle Scholar
  106. 106.
    Xu R, Luo Y, Chambers C. Assessing the effect of vaccine on spontaneous abortion using time-dependent covariates Cox models. Pharmacoepidemiol Drug Saf. 2012;21(8):844–50.  https://doi.org/10.1002/pds.3301.CrossRefPubMedGoogle Scholar
  107. 107.
    Schisterman EF, Cole SR, Ye A, Platt RW. Accuracy loss due to selection bias in cohort studies with left truncation. Paediatr Perinat Epidemiol. 2013;27(5):491–502.  https://doi.org/10.1111/ppe.12073.CrossRefPubMedPubMedCentralGoogle Scholar
  108. 108.
    Beau AB, Hurault-Delarue C, Vidal S, Guitard C, Vayssiere C, Petiot D, et al. Pandemic A/H1N1 influenza vaccination during pregnancy: a comparative study using the EFEMERIS database. Vaccine. 2014;32(11):1254–8.  https://doi.org/10.1016/j.vaccine.2014.01.021.CrossRefPubMedGoogle Scholar
  109. 109.
    Pasternak B, Svanstrom H, Molgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ. 2012;344:e2794.  https://doi.org/10.1136/bmj.e2794.CrossRefPubMedPubMedCentralGoogle Scholar
  110. 110.
    Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA, et al. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12. Vaccine. 2017;35(40):5314–22.  https://doi.org/10.1016/j.vaccine.2017.06.069.CrossRefPubMedPubMedCentralGoogle Scholar
  111. 111.
    CDC. Flu vaccination & addressing concerns pregnatn women might have about flu vaccine safety. https://www.cdc.gov/flu/professionals/vaccination/vaccination-possible-safety-signal.html. Accessed 6 September 2019.
  112. 112.
    Benowitz I, Esposito DB, Gracey KD, Shapiro ED, Vázquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis. 2010;51(12):1355–61.  https://doi.org/10.1086/657309.CrossRefPubMedPubMedCentralGoogle Scholar
  113. 113.
    Dabrera G, Zhao H, Andrews N, Begum F, Green H, Ellis J, et al. Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013/14. Euro Surveill. 2014;19(45):20959.  https://doi.org/10.2807/1560-7917.es2014.19.45.20959.CrossRefPubMedGoogle Scholar
  114. 114.
    Molgaard-Nielsen D, Fischer TK, Krause TG, Hviid A. Effectiveness of maternal immunization with trivalent inactivated influenza vaccine in pregnant women and their infants. J Intern Med. 2019.  https://doi.org/10.1111/joim.12947.CrossRefGoogle Scholar
  115. 115.
    Thompson MG, Li DK, Shifflett P, Sokolow LZ, Ferber JR, Kurosky S, et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis. 2014;58(4):449–57.  https://doi.org/10.1093/cid/cit750.CrossRefPubMedGoogle Scholar
  116. 116.
    Thompson MG, Kwong JC, Regan AK, Katz MA, Drews SJ, Azziz-Baumgartner E, et al. Influenza vaccine effectiveness in preventing influenza-associated hospitalizations during pregnancy: a multi-country retrospective test negative design study, 2010-2016. Clin Infect Dis. 2019;68(9):1444–53.  https://doi.org/10.1093/cid/ciy737.CrossRefPubMedGoogle Scholar
  117. 117.
    Regan AK, Klerk N, Moore HC, Omer SB, Shellam G, Effler PV. Effectiveness of seasonal trivalent influenza vaccination against hospital-attended acute respiratory infections in pregnant women: a retrospective cohort study. Vaccine. 2016;34(32):3649–56.  https://doi.org/10.1016/j.vaccine.2016.05.032.CrossRefPubMedGoogle Scholar
  118. 118.
    Regan AK, de Klerk N, Moore HC, Omer SB, Shellam G, Effler PV. Effect of maternal influenza vaccination on hospitalization for respiratory infections in newborns: a retrospective cohort study. Pediatr Infect Dis J. 2016;35(10):1097–103.  https://doi.org/10.1097/inf.0000000000001258.CrossRefPubMedGoogle Scholar
  119. 119.
    Ohfuji S, Deguchi M, Tachibana D, Koyama M, Takagi T, Yoshioka T, et al. Protective effect of maternal influenza vaccination on influenza in their infants: a prospective cohort study. J Infect Dis. 2018;217(6):878–86.  https://doi.org/10.1093/infdis/jix629.CrossRefPubMedGoogle Scholar
  120. 120.
    Nunes MC, Cutland CL, Jones S, Downs S, Weinberg A, Ortiz JR, et al. Efficacy of maternal influenza vaccination against all-cause lower respiratory tract infection hospitalizations in young infants: results from a randomized controlled trial. Clin Infect Dis. 2017;65(7):1066–71.  https://doi.org/10.1093/cid/cix497.CrossRefPubMedPubMedCentralGoogle Scholar
  121. 121.
    France EK, Smith-Ray R, McClure D, Hambidge S, Xu S, Yamasaki K, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med. 2006;160(12):1277–83.  https://doi.org/10.1001/archpedi.160.12.1277.CrossRefPubMedGoogle Scholar
  122. 122.
    Black SB, Shinefield HR, France EK, Fireman BH, Platt ST, Shay D. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol. 2004;21(6):333–9.  https://doi.org/10.1055/s-2004-831888.CrossRefPubMedGoogle Scholar
  123. 123.
    Fell DB, Wilson K, Ducharme R, Hawken S, Sprague AE, Kwong JC, et al. Infant respiratory outcomes associated with prenatal exposure to maternal 2009 A/H1N1 influenza vaccination. PloS One. 2016;11(8):e0160342.  https://doi.org/10.1371/journal.pone.0160342.CrossRefPubMedPubMedCentralGoogle Scholar
  124. 124.
    Chan HJ, Chang JY, Erickson SR, Wang CC. Influenza vaccination among pregnant women in the United States: findings from the 2012-2016 National Health Interview Survey. J Womens Health. 2019;28(7):965–75.  https://doi.org/10.1089/jwh.2018.7139.CrossRefGoogle Scholar
  125. 125.
    Office of Disease Prevention and Health Promotion. IID-12.10 Increase the percentage of pregnant women who are vaccinated against seasonal influenza. https://www.healthypeople.gov/node/4660/data_details. Accessed 31 July 2019.
  126. 126.
    Lutz CS, Carr W, Cohn A, Rodriguez L. Understanding barriers and predictors of maternal immunization: identifying gaps through an exploratory literature review. Vaccine. 2018;36(49):7445–55.  https://doi.org/10.1016/j.vaccine.2018.10.046.CrossRefPubMedGoogle Scholar
  127. 127.
    Wilson RJ, Paterson P, Jarrett C, Larson HJ. Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine. 2015;33(47):6420–9.  https://doi.org/10.1016/j.vaccine.2015.08.046.CrossRefPubMedGoogle Scholar
  128. 128.
    Eppes C, Wu A, You W, Cameron KA, Garcia P, Grobman W. Barriers to influenza vaccination among pregnant women. Vaccine. 2013;31(27):2874–8.  https://doi.org/10.1016/j.vaccine.2013.04.031.CrossRefPubMedGoogle Scholar
  129. 129.
    Yuen CY, Tarrant M. Determinants of uptake of influenza vaccination among pregnant women - a systematic review. Vaccine. 2014;32(36):4602–13.  https://doi.org/10.1016/j.vaccine.2014.06.067.CrossRefPubMedGoogle Scholar
  130. 130.
    Mak DB, Regan AK, Joyce S, Gibbs R, Effler PV. Antenatal care provider’s advice is the key determinant of influenza vaccination uptake in pregnant women. Austr N Z J Obstet Gynecol. 2015;55(2):131–7.  https://doi.org/10.1111/ajo.12292.CrossRefGoogle Scholar
  131. 131.
    Bednarczyk RA, Chamberlain A, Mathewson K, Salmon DA, Omer SB. Practice-, Provider-, and Patient-level interventions to improve preventive care: development of the P3 model. Prev Med Rep. 2018;11:131–8.  https://doi.org/10.1016/j.pmedr.2018.06.009.CrossRefPubMedPubMedCentralGoogle Scholar
  132. 132.
    Palmer S, Pudwell J, Smith GN, Reid RL. Optimizing participation of pregnant women in clinical trials: factors influencing decisions about participation in medication and vaccine trials. J Obstet Gynaecol Can. 2016;38(10):945–54.  https://doi.org/10.1016/j.jogc.2016.04.100.CrossRefPubMedGoogle Scholar
  133. 133.
    Cutland CL, Cunnington M, Olugbosi M, Jones SA, Hugo A, Maharaj K, et al. Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income country. Vaccine. 2015;33(47):6406–12.  https://doi.org/10.1016/j.vaccine.2015.08.040.CrossRefPubMedGoogle Scholar
  134. 134.
    Wilcox CR, Calvert A, Metz J, Kilich E, MacLeod R, Beadon K, et al. Attitudes of pregnant women and healthcare professionals toward clinical trials and routine implementation of antenatal vaccination against respiratory syncytial virus: a multicenter questionnaire study. Pediatr Infect Dis J. 2019;38(9):944–51.  https://doi.org/10.1097/inf.0000000000002384.CrossRefPubMedGoogle Scholar
  135. 135.
    Top KA, Arkell C, Scott H, McNeil SA, Mannerfeldt J, Ortiz JR, et al. Effect of package insert language on health-care providers’ perceptions of influenza vaccination safety during pregnancy. Lancet Global Health. 2016;4(10):e690–1.  https://doi.org/10.1016/s2214-109x(16)30182-6.CrossRefPubMedGoogle Scholar
  136. 136.
    Beeler JA, Lambach P, Fulton TR, Narayanan D, Ortiz JR, Omer SB. A systematic review of ethical issues in vaccine studies involving pregnant women. Hum Vaccin Immunother. 2016;12(8):1952–9.  https://doi.org/10.1080/21645515.2016.1186312.CrossRefPubMedPubMedCentralGoogle Scholar
  137. 137.
    Krubiner CB, Faden RR, Karron RA, Little MO, Lyerly AD, Abramson JS, et al. Pregnant women & vaccines against emerging epidemic threats: ethics guidance for preparedness, research, and response. Vaccine. 2019; in press.  https://doi.org/10.1016/j.vaccine.2019.01.011.
  138. 138.
    McQuaid F, Jones C, Stevens Z, Meddaugh G, O’Sullivan C, Donaldson B, et al. Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation. Acta Obstet Gynecol Scand. 2018;97(3):330–40.  https://doi.org/10.1111/aogs.13288.CrossRefPubMedGoogle Scholar
  139. 139.
    Goldfarb IT, Jaffe E, James K, Lyerly AD. Pregnant women’s attitudes toward Zika virus vaccine trial participation. Vaccine. 2018;36(45):6711–7.  https://doi.org/10.1016/j.vaccine.2018.09.042.CrossRefPubMedPubMedCentralGoogle Scholar
  140. 140.
    Schwartz DA. Clinical trials and administration of Zika virus vaccine in pregnant women: lessons (that should have been) learned from excluding immunization with the Ebola vaccine during pregnancy and lactation. Vaccines (Basel). 2018;6(4):E81.  https://doi.org/10.3390/vaccines6040081.CrossRefGoogle Scholar
  141. 141.
    Ellingson MK, Dudley MZ, Limaye RJ, Salmon DA, O’Leary ST, Omer SB. Enhancing uptake of influenza maternal vaccine. Expert Rev Vaccines. 2019;18(2):191–204.  https://doi.org/10.1080/14760584.2019.1562907.CrossRefPubMedGoogle Scholar
  142. 142.
    Wong VW, Lok KY, Tarrant M. Interventions to increase the uptake of seasonal influenza vaccination among pregnant women: a systematic review. Vaccine. 2016;34(1):20–32.  https://doi.org/10.1016/j.vaccine.2015.11.020.CrossRefPubMedGoogle Scholar
  143. 143.
    Stockwell MS, Westhoff C, Kharbanda EO, Vargas CY, Camargo S, Vawdrey DK, et al. Influenza vaccine text message reminders for urban, low-income pregnant women: a randomized controlled trial. Am J Public Health. 2014;104(Suppl 1):e7–12.  https://doi.org/10.2105/ajph.2013.301620.CrossRefPubMedPubMedCentralGoogle Scholar
  144. 144.
    Yudin MH, Mistry N, De Souza LR, Besel K, Patel V, Blanco Mejia S, et al. Text messages for influenza vaccination among pregnant women: a randomized controlled trial. Vaccine. 2017;35(5):842–8.  https://doi.org/10.1016/j.vaccine.2016.12.002.CrossRefPubMedGoogle Scholar
  145. 145.
    Regan AK, Bloomfield L, Peters I, Effler PV. Randomized controlled trial of text message reminders for increasing influenza vaccination. Ann Fam Med. 2017;15(6):507–14.  https://doi.org/10.1370/afm.2120.CrossRefPubMedPubMedCentralGoogle Scholar
  146. 146.
    Kochhar S, Edwards KM, Ropero Alvarez AM, Moro PL, Ortiz JR. Introduction of new vaccines for immunization in pregnancy - programmatic, regulatory, safety and ethical considerations. Vaccine. 2019;37(25):3267–77.  https://doi.org/10.1016/j.vaccine.2019.04.075.CrossRefPubMedPubMedCentralGoogle Scholar
  147. 147.
    Sobanjo-Ter Meulen A, Munoz FM, Kaslow DC, Klugman KP, Omer SB, Vora P, et al. Maternal interventions vigilance harmonization in low- and middle-income countries: stakeholder meeting report; Amsterdam, May 1-2, 2018. Vaccine. 2019;37(20):2643–50.  https://doi.org/10.1016/j.vaccine.2019.03.060.CrossRefPubMedPubMedCentralGoogle Scholar
  148. 148.
    Kochhar S, Clarke E, Izu A, Emmanuel Kekane-Mochwari K, Cutland CL. Immunization in pregnancy safety surveillance in low and middle-income countries- field performance and validation of novel case definitions. Vaccine. 2019;37(22):2967–74.  https://doi.org/10.1016/j.vaccine.2019.03.074.CrossRefPubMedGoogle Scholar
  149. 149.
    Krishnaswamy S, Lambach P, Giles ML. Key considerations for successful implementation of maternal immunization programs in low and middle income countries. Hum Vaccin Immunother. 2019;15(4):942–50.  https://doi.org/10.1080/21645515.2018.1564433.CrossRefPubMedPubMedCentralGoogle Scholar
  150. 150.
    Sobanjo-Ter Meulen A, Abramson J, Mason E, Rees H, Schwalbe N, Bergquist S, et al. Path to impact: a report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin - January 29-30, 2015. Vaccine. 2015;33(47):6388–95.  https://doi.org/10.1016/j.vaccine.2015.08.047.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Annette K. Regan
    • 1
    • 2
    Email author
  • Siri E. Håberg
    • 3
  • Deshayne B. Fell
    • 4
    • 5
  1. 1.School of Public HealthTexas A&M UniversityCollege StationUSA
  2. 2.Fielding School of Public HealthUniversity of California Los AngelesLos AngelesUSA
  3. 3.Centre for Fertility and HealthNorwegian Institute of Public HealthOsloNorway
  4. 4.School or Epidemiology and Public HealthUniversity of OttawaOttawaCanada
  5. 5.Children’s Hospital of Eastern Ontario (CHEO) Research InstituteOttawaCanada

Personalised recommendations